Class information for:
Level 1: INSULAR CARCINOMA//COLUMNAR CELL CARCINOMA//HURTHLE CELL CARCINOMA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
14015 734 27.0 70%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
35 32606 THYROID CANCER//THYROID//THYROGLOBULIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INSULAR CARCINOMA Author keyword 43 79% 4% 27
2 COLUMNAR CELL CARCINOMA Author keyword 26 100% 1% 11
3 HURTHLE CELL CARCINOMA Author keyword 23 57% 4% 27
4 HURTHLE CELL Author keyword 21 59% 3% 24
5 DIFFUSE SCLEROSING VARIANT Author keyword 19 76% 2% 13
6 TALL CELL VARIANT Author keyword 14 55% 2% 18
7 HURTHLE CELLS Author keyword 11 67% 1% 10
8 POORLY DIFFERENTIATED CARCINOMA Author keyword 10 50% 2% 15
9 HURTHLE CELL NEOPLASM Author keyword 7 53% 1% 9
10 HURTHLE CELL TUMOR Author keyword 7 53% 1% 9

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 INSULAR CARCINOMA 43 79% 4% 27 Search INSULAR+CARCINOMA Search INSULAR+CARCINOMA
2 COLUMNAR CELL CARCINOMA 26 100% 1% 11 Search COLUMNAR+CELL+CARCINOMA Search COLUMNAR+CELL+CARCINOMA
3 HURTHLE CELL CARCINOMA 23 57% 4% 27 Search HURTHLE+CELL+CARCINOMA Search HURTHLE+CELL+CARCINOMA
4 HURTHLE CELL 21 59% 3% 24 Search HURTHLE+CELL Search HURTHLE+CELL
5 DIFFUSE SCLEROSING VARIANT 19 76% 2% 13 Search DIFFUSE+SCLEROSING+VARIANT Search DIFFUSE+SCLEROSING+VARIANT
6 TALL CELL VARIANT 14 55% 2% 18 Search TALL+CELL+VARIANT Search TALL+CELL+VARIANT
7 HURTHLE CELLS 11 67% 1% 10 Search HURTHLE+CELLS Search HURTHLE+CELLS
8 POORLY DIFFERENTIATED CARCINOMA 10 50% 2% 15 Search POORLY+DIFFERENTIATED+CARCINOMA Search POORLY+DIFFERENTIATED+CARCINOMA
9 HURTHLE CELL NEOPLASM 7 53% 1% 9 Search HURTHLE+CELL+NEOPLASM Search HURTHLE+CELL+NEOPLASM
10 HURTHLE CELL TUMOR 7 53% 1% 9 Search HURTHLE+CELL+TUMOR Search HURTHLE+CELL+TUMOR

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SOLID PATTERNS 32 85% 2% 17
2 TURIN PROPOSAL 18 83% 1% 10
3 FOLLICULAR CARCINOMAS 18 59% 3% 20
4 COLUMNAR CELL CARCINOMA 14 59% 2% 16
5 INSULAR CARCINOMA 14 59% 2% 16
6 DIFFUSE SCLEROSING VARIANT 13 43% 3% 23
7 WARTHIN LIKE TUMOR 11 67% 1% 10
8 FIBROMATOSIS LIKE STROMA 11 100% 1% 6
9 INSULAR COMPONENT 9 59% 1% 10
10 INFREQUENT SUBTYPE 8 100% 1% 5

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA 2011 25 31 74%
Poorly differentiated thyroid cancer 2014 5 40 65%
Aggressive variants of papillary thyroid cancer 2013 6 20 75%
Hurthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003 2009 14 19 68%
The thyroid Hurthle (oncocytic) cell and its associated pathologic conditions - A surgical pathology and cytopathology review 2008 43 83 67%
Aggressive variants of follicular cell derived thyroid carcinoma; the so called "Real Thyroid Carcinomas' 2013 7 87 48%
A review of thyroid cancer with intermediate differentiation 2004 33 64 84%
Poorly Differentiated Thyroid Carcinoma A Cytologic-histologic Review 2009 11 57 58%
Hurthle cell tumours of the thyroid. Personal experience and review of the literature 2009 10 36 58%
Comprehensive Literature Review: Recent Advances in Diagnosing and Managing Patients with Poorly Differentiated Thyroid Carcinoma 2013 3 23 57%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ENDOCRINOL ANAT PATOL 1 100% 0.3% 2
2 DIABETOL ENDOCRINE DIS 1 33% 0.3% 2
3 CIRUGIA ONCOLOG MAXILO IAL 1 50% 0.1% 1
4 FNA SERV 1 50% 0.1% 1
5 INFORMAT PATHOL 1 50% 0.1% 1
6 IPATIMUP MOLEC PATHOL IMMUNOL 1 50% 0.1% 1
7 NUCL MED GEN SURG 1 50% 0.1% 1
8 SCOTTE HOSP 1 50% 0.1% 1
9 ENDOCRINE SURG UNIT SURG 0 33% 0.1% 1
10 HOSP BELLARIA 0 33% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000234459 RET PTC//PAPILLARY THYROID CARCINOMA//HBME 1
2 0.0000215299 THYROID NODULE//THYROID NODULES//FOLLICULAR NEOPLASM
3 0.0000176345 DIFFERENTIATED THYROID CANCER//THYROGLOBULIN//DIFFERENTIATED THYROID CARCINOMA
4 0.0000173826 SOLID CELL NESTS//THYROID METASTASIS//ULTIMOBRANCHIAL BODY
5 0.0000141286 ANAPLASTIC THYROID CANCER//ANAPLASTIC THYROID CARCINOMA//LENVATINIB
6 0.0000118717 CHRONIC LYMPHOCYTIC THYROIDITIS//LYMPHOCYTIC THYROIDITIS//ADVANCED TUMOR STAGE
7 0.0000065187 MALIGNANCY ASSOCIATED CHANGES//NUCLEAR TEXTURE ANALYSIS//KARYOMETRY
8 0.0000060588 S PHASE FRACTION//ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY//DNA PLOIDY
9 0.0000058842 FAMILIAL NON MEDULLARY THYROID CANCER//FAMILIAL THYROID CARCINOMA//CANC MOL GENET GEMOCA
10 0.0000051249 CHERNOBYL//PEDIATRIC THYROID CANCER//CHERNOBYL NUCLEAR ACCIDENT